Carl Sandler resigns from Enochian Biosciences board effective March 25, 2022

Lunai Bioworks Inc.

Carl Sandler resigned as board member on March 25, 2022 to focus on other business ventures.
Resignation effective immediately; not due to any disagreement with company operations, policies, or practices.
No replacement named; CEO Mark R. Dybul signed the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Carl Sandler

member of the Board of Directors

LNAI · Lunai Bioworks Inc.

Effective: 2022-03-25
Filed: March 29, 2022, 7:59 PM ET

On March 25, 2022, Carl Sandler provided notice of his resignation as a member of the Board of Directors of Enochian Biosciences Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carl Sandler resigned as member of the Board of Directors at Lunai Bioworks Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On March 25, 2022, Carl Sandler provided notice of his resignation as a member of the Board of Directors of Enochian Biosciences Inc.

View on SEC.gov

Lunai Bioworks Inc. filing history →

Source: SEC EDGAR

accession 0001731122-22-000565

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.